Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03997643

Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial

Preservation of Swallowing in Resected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects: A Randomized Trial

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized treatment study is to formally compare quality of life in patients with at least one pN0 hemi-neck after resection of a squamous cell carcinoma of the oral cavity treated with a primary radiation therapy versus a secondary targeted radiation therapy approach, to provide a high level of evidence to guide the selection of treatment options.

Detailed description

The goal of this randomized treatment study is to formally compare quality of life in patients with at least one pN0 hemi-neck after resection of a squamous cell carcinoma of the oral cavity treated with a primary radiation therapy versus a secondary targeted radiation therapy approach, to provide a high level of evidence to guide the selection of treatment options. The study will require a sample size of 90 patients randomized in a 2:3 between the two arms. Arm 1 (standard radiation therapy to tumor location and surrounding area) and Arm 2 (targeted radiation therapy to tumor location). Patients will be followed for a total of 5 years.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiotherapy to all dissected areasPost operative radiation therapy +/- chemotherapy based on historic treatment volumes (including the primary site, dissected areas +/- elective areas
RADIATIONOmit radiation to pN0 neckpost operation radiation therapy +/- chemotherapy that avoids targeting the dissected pN0 neck

Timeline

Start date
2019-09-06
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2019-06-25
Last updated
2023-08-03

Locations

8 sites across 4 countries: United States, Canada, Ireland, United Kingdom

Source: ClinicalTrials.gov record NCT03997643. Inclusion in this directory is not an endorsement.